home / stock / xvipf / xvipf short
Short Information | Xvivo Perfusion Ab Ord (OTCMKTS:XVIPF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,209 |
Total Actual Volume | 4,423 |
Short Trends | |
---|---|
Cover Days | 3 |
Short Days | 17 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 160 |
Average Short Percentage | 87.34% |
Is there a XVIPF Short Squeeze or Breakout about to happen?
See the XVIPF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-15-2024 | $48.45 | $48.45 | $48.45 | $48.45 | 240 | 225 | 93.75% |
07-12-2024 | $47.12 | $47.85 | $48.04 | $47.12 | 591 | 204 | 34.52% |
07-11-2024 | $39.39 | $39.626 | $39.626 | $39.39 | 505 | 505 | 100% |
07-10-2024 | $39.34 | $39.34 | $39.34 | $39.34 | 101 | 100 | 99.01% |
07-09-2024 | $0 | $39.95 | $0 | $0 | 47 | 47 | 100% |
07-08-2024 | $39.95 | $39.95 | $39.95 | $39.95 | 100 | 100 | 100% |
07-05-2024 | $38.85 | $38.85 | $38.85 | $38.85 | 129 | 110 | 85.27% |
07-02-2024 | $38.24 | $38.24 | $38.24 | $38.24 | 350 | 350 | 100% |
06-17-2024 | $0 | $42.76 | $0 | $0 | 3 | 3 | 100% |
06-14-2024 | $0 | $42.76 | $0 | $0 | 290 | 98 | 33.79% |
06-13-2024 | $42.76 | $42.76 | $42.76 | $42.76 | 177 | 177 | 100% |
06-10-2024 | $0 | $43.09 | $0 | $0 | 73 | 73 | 100% |
06-07-2024 | $43.11 | $43.09 | $43.11 | $43.09 | 733 | 233 | 31.79% |
05-31-2024 | $41.77 | $41.77 | $41.77 | $41.77 | 100 | 100 | 100% |
05-29-2024 | $39.37 | $39.37 | $39.37 | $39.37 | 100 | 100 | 100% |
05-28-2024 | $37.02 | $37.02 | $37.02 | $37.02 | 210 | 210 | 100% |
05-22-2024 | $0 | $37.86 | $0 | $0 | 46 | 46 | 100% |
05-20-2024 | $37.77 | $37.86 | $37.86 | $37.77 | 233 | 233 | 100% |
05-16-2024 | $36.85 | $37.09 | $37.09 | $36.85 | 320 | 220 | 68.75% |
05-15-2024 | $0 | $34.9 | $0 | $0 | 75 | 75 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Xvivo Perfusion Ab Ord Company Name:
XVIPF Stock Symbol:
OTCMKTS Market:
GOTHENBURG, SWEDEN / ACCESSWIRE / July 12, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Second quarter 2024 (Apr 1 - Jun 30) • Net sales amounted to SEK 210.3 million (154.6), corresponding to growth of 36 percent in SEK and 35 percent in local currencies. Organic growth a...
GOTHENBURG, SWEDEN / ACCESSWIRE / April 24, 2024 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL)(FRA:3XV) First quarter 2024 (Jan 1 - Mar 31) • Net sales amounted to SEK 186.0 million (140.6), corresponding to an increase of 32 percent in SEK and equivalent increase, 32 percent, adjusted ...
GOTHENBURG, SWEDEN / ACCESSWIRE / April 11, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Today, at the 2024 International Society of Heart and Lung Transplantation meeting in Prague, Czech Republic, the results from XVIVO's clinical trial, NIHP2019, in heart transplantation were pres...